BioCentury
ARTICLE | Financial News

Isis Pharmaceuticals completes follow-on

May 13, 2013 7:00 AM UTC

Isis Pharmaceuticals Inc. (NASDAQ:ISIS), Carlsbad, Calif. Business: Cancer, Endocrine/Metabolic, Cardiovascular Date completed: 5/8/13 Type: Follow-on Raised: $171 million Shares: 9 million Price: $19...